Alexia Ghazi

Baylor University Medical Center — United States

Medicine · Health Sciences

10h-index2.7kcitations26works2.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(10), Immunotherapy and Immune Responses(4), Virus-based gene therapy research(4), Cytomegalovirus and herpesvirus research(2), Monoclonal and Polyclonal Antibodies Research(2)

Publications24 total

Emerging Trends in mRNA Vaccine Technology: Beyond Infectious Diseases
Egyptian Journal of Chemistry·2024· 5 citedOpen Access
A 20-year-old woman with chronic cough and dyspnea
Baylor University Medical Center Proceedings·2024Open Access
Sporadic Lymphangioleiomyomatosis Without a TSC1 or TSC2 Mutation
2022
P159 MAST CELL ACTIVATION SYNDROME AND MANAGEMENT OF ITS PROTEAN MANIFESTATIONS
Annals of Allergy Asthma & Immunology·2021
Bradycardia in Recent Heart Transplant: Will the Microscope Illuminate the True Answer?
Methodist DeBakey Cardiovascular Journal·2021Open Access
Heterotopic gastric mucosa and intestinal atresia in a neonate
Baylor University Medical Center Proceedings·2021Open Access
HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial
UNC Libraries·2020· 68 citedOpen Access
Vascular lakes after doxorubicin drug-eluting bead chemoembolization with histologic analysis
Baylor University Medical Center Proceedings·2018· 1 citedOpen Access
Diagnosis of Malignant Potential in Mucinous Peritoneal Neoplasms by Characterization of Mucin Carbohydrate Structure
Cellular and Molecular Gastroenterology and Hepatology·2018· 1 citedOpen Access
HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
JAMA Oncology·2017· 807 citedOpen Access
Complex Carbohydrate Marker to Distinguish Mucins from Low Grade Neoplasms versus Adenocarcinomas in the Colon Causing Pseudomyxoma Peritonei
The American Journal of Gastroenterology·2016
Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.
Journal for ImmunoTherapy of Cancer·2015· 61 citedOpen Access
Fatal Pulmonary Tumor Thrombotic Microangiopathy Caused by Undiagnosed Metastatic Gastric Adenocarcinoma
Baylor University Medical Center Proceedings·2015· 12 citedOpen Access
Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients
Journal of Neuro-Oncology·2015· 29 citedOpen Access
Autologous HER2 CMV bispecific CAR T cells for progressive glioblastoma: Results from a phase I clinical trial.
Journal of Clinical Oncology·2015· 9 cited
19. A Phase I Clinical Trial of Autologous HER2 CMV Bispecific CAR T Cells for Progressive Glioblastoma
Molecular Therapy·2015· 1 citedOpen Access
Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Journal of Clinical Oncology·2015· 959 citedOpen Access
TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
Molecular Therapy — Nucleic Acids·2013· 450 citedOpen Access
METHODS: ORIGINAL ARTICLE TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
2013
Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of Glioblastoma
Journal of Immunotherapy·2012· 69 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Nabil Ahmed(11), Stephen Gottschalk(11), Vita S. Brawley(10), Helen E. Heslop(9), Meenakshi Hegde(8), Aidin Ashoori(8), Gianpietro Dotti(8), Winfried S. Wels(8), John Hicks(7), Cliona M. Rooney(7), Suzanne Z. Powell(7), Adrian P. Gee(6), Claudia Gerken(5), Hao Liu(5), Malcolm K. Brenner(5), Oumar Diouf(5), Amanda Wakefield(5), Yvonne Kew(5), David S. Baskin(5), Robert G. Grossman(5)